On 14 April 1967, the Tenovus Institute for Cancer Research, based at the University Hospital of Wales in Cardiff, was opened by HRH Princess Margaret. Since then, the Institute has produced industry-leading research, changing the lives of cancer patients all over the world.
In its 50 years, the Institute has made some ground-breaking cancer discoveries. In 1975, researchers at the Institute found that a contraceptive pill was very effective at halting the growth of certain breast cancers, resulting in the discovery of Tamoxifen. Today, tamoxifen is taken by millions of women each year worldwide to treat and prevent breast cancer.
Researchers at the Institute also played a key role in the research and clinical trials that led to the drug Zoladex, which has become a common therapy for both breast and prostate cancer patients.
Today, we continue to fund world-class cancer research. We fund research projects that are unique and diverse, but each share a common goal; to improve the lives of people affected by cancer and prevent cancer from occurring in the first instance.
Our research projects can be broadly divided into two main areas:
Tenovus Cancer Care lab funded research is continuing to further our knowledge of how cancers form, creating new drugs for some of the hardest to treat cancers and identifying new genes that could show if a person is at a high risk of getting cancer.
Not all research happens in a lab and not all cancer research is looking for a cure. Some of it looks at how we can make life better for people living with cancer today. It’s research that involves, and takes place in the community.